losartan and 1-methyl-4-phenylpyridinium

losartan has been researched along with 1-methyl-4-phenylpyridinium in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiueh, CC; de Oliveira, AM; Saavedra, JM; Viswanathan, M; Wu, RM1
Banninger, GP; Cantu, D; Das, M; Griffin, WS; Jones, SM; Marriott, B; Rachubinski, AL; Thornton, J; Zawada, WM1

Other Studies

2 other study(ies) available for losartan and 1-methyl-4-phenylpyridinium

ArticleYear
[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
    Cellular and molecular neurobiology, 1994, Volume: 14, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding Sites; Biphenyl Compounds; Brain; Brain Injuries; Imidazoles; Iodine Radioisotopes; Losartan; Male; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Substantia Nigra; Tetrazoles

1994
Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.
    Journal of neuroinflammation, 2011, Oct-05, Volume: 8

    Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line; Dopaminergic Neurons; Electron Transport Complex I; Female; Herbicides; Hydrogen Peroxide; Losartan; Mice; Mice, Inbred C57BL; NADPH Oxidases; Oxidants; Protein Subunits; Rats; Reactive Oxygen Species; RNA, Small Interfering; Substantia Nigra

2011